Skip to content
May 9, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Popular Tags
  • Patient Advocacy and Support
  • Medical Research and Clinical Trials
  • Genomics and Precision Medicine
  • Survivorship and Post-Treatment
  • Chemotherapy and Targeted Therapy
  • Global Breast Cancer Awareness
  • Treatment Innovations
  • Integrative Oncology and Holistic Care
  • Clinical Oncology Education
  • Psychosocial Support and Mental Health
Breaking News
odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation beyond-the-greige-why-your-gym-wardrobe-needs-a-color-revolution Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution

Main News

odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0
beyond-the-greige-why-your-gym-wardrobe-needs-a-color-revolution
  • Integrative Oncology and Holistic Care

Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution

Asep Darmawan May 9, 2026 0
  • Recommended
  • Popular
  • Archive
  • Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
    • Chemotherapy and Targeted Therapy

    Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

    Raul Delapena Setiawan May 9, 2026 0
  • The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
    • Breast Cancer Legislation and Policy

    The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

    Neng Nana May 9, 2026 0
  • Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
    • Patient Advocacy and Support

    Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

    Basiran May 9, 2026 0
  • Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
    • Metastatic Breast Cancer Research

    Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

    Layla Zulfa May 9, 2026 0
  • Global Health Preparedness: Inside "Exercise Polaris II" and the Future of Pandemic Defense global-health-preparedness-inside-exercise-polaris-ii-and-the-future-of-pandemic-defense
    • Global Breast Cancer Awareness

    Global Health Preparedness: Inside "Exercise Polaris II" and the Future of Pandemic Defense

    Siti Muinah May 9, 2026 0
  • Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day® beyond-the-diagnosis-uniting-the-world-for-the-39th-national-cancer-survivors-day
    • Survivorship and Post-Treatment

    Beyond the Diagnosis: Uniting the World for the 39th National Cancer Survivors Day®

    Lina Irawan May 8, 2026 0
  • Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients detalimogene-voraplasmid-shows-promising-efficacy-and-tolerability-in-bcg-unresponsive-nmibc-offering-new-hope-for-patients
    • Medical Research and Clinical Trials

    Detalimogene Voraplasmid Shows Promising Efficacy and Tolerability in BCG-Unresponsive NMIBC, Offering New Hope for Patients

    Lina Irawan May 9, 2026 0
  • A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer a-paradigm-shift-in-oncology-nccn-guidelines-embrace-ai-to-predict-not-just-detect-breast-cancer
    • Patient Advocacy and Support

    A Paradigm Shift in Oncology: NCCN Guidelines Embrace AI to Predict, Not Just Detect, Breast Cancer

    Lina Irawan May 9, 2026 0
  • Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
    • Chemotherapy and Targeted Therapy

    Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

    Raul Delapena Setiawan May 9, 2026 0
  • The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
    • Breast Cancer Legislation and Policy

    The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

    Neng Nana May 9, 2026 0
  • Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
    • Patient Advocacy and Support

    Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

    Basiran May 9, 2026 0
  • Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
    • Metastatic Breast Cancer Research

    Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

    Layla Zulfa May 9, 2026 0

Featured News

odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0

General

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0

Opinion

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0

More

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0
Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
In a significant milestone for the biotechnology industry, Odyssey Therapeutics has officially made its debut on the...
Read More Read more about Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence
The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
As Medicaid spending on prescription drugs continues to climb, the federal government and state legislatures are intensifying...
Read More Read more about The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs
Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
CITY OF INDUSTRY / NATIONAL CANCER RESEARCH UPDATE — In a decisive move to address the deadliest...
Read More Read more about Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer
Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0
By Editorial Staff As the medical community continues to push the boundaries of oncology, the quest for...
Read More Read more about Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation
Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution beyond-the-greige-why-your-gym-wardrobe-needs-a-color-revolution
  • Integrative Oncology and Holistic Care

Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution

Asep Darmawan May 9, 2026 0
The Monochrome Epidemic in Modern Fitness Walking into a modern fitness center or a boutique yoga studio...
Read More Read more about Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution
The Genetic Blueprint for a Greener Future: How Genomics is Saving Our Forests the-genetic-blueprint-for-a-greener-future-how-genomics-is-saving-our-forests
  • Genomics and Precision Medicine

The Genetic Blueprint for a Greener Future: How Genomics is Saving Our Forests

Sagoh May 9, 2026 0
Introduction: Decoding the Silent Giants For centuries, humanity has viewed forests as static backdrops—passive witnesses to the...
Read More Read more about The Genetic Blueprint for a Greener Future: How Genomics is Saving Our Forests
Revolutionizing Breast Cancer Screening: Landmark WISDOM Study Advocates for Personalized Risk-Based Approach revolutionizing-breast-cancer-screening-landmark-wisdom-study-advocates-for-personalized-risk-based-approach
  • Medical Research and Clinical Trials

Revolutionizing Breast Cancer Screening: Landmark WISDOM Study Advocates for Personalized Risk-Based Approach

Asep Darmawan May 9, 2026 0
SAN FRANCISCO, CA – December 12, 2023 – A groundbreaking new study, known as the WISDOM study,...
Read More Read more about Revolutionizing Breast Cancer Screening: Landmark WISDOM Study Advocates for Personalized Risk-Based Approach
Beyond the Surface: The Vital Role of Scar Management in Cancer Recovery beyond-the-surface-the-vital-role-of-scar-management-in-cancer-recovery
  • Psychosocial Support and Mental Health

Beyond the Surface: The Vital Role of Scar Management in Cancer Recovery

Suro Senen May 9, 2026 0
By Editorial Staff, based on insights from Berfin Mahmut, PT, DPT, CLT-LANA, OnCS For many cancer survivors,...
Read More Read more about Beyond the Surface: The Vital Role of Scar Management in Cancer Recovery
A Paradigm Shift in Neuro-Oncology: UCLA Researchers Advance Tailored EGFR-Targeted Therapy for Glioblastoma a-paradigm-shift-in-neuro-oncology-ucla-researchers-advance-tailored-egfr-targeted-therapy-for-glioblastoma
  • Treatment Innovations

A Paradigm Shift in Neuro-Oncology: UCLA Researchers Advance Tailored EGFR-Targeted Therapy for Glioblastoma

Laily UPN May 9, 2026 0
In the relentless battle against glioblastoma—the most aggressive and lethal form of primary brain cancer—a team of...
Read More Read more about A Paradigm Shift in Neuro-Oncology: UCLA Researchers Advance Tailored EGFR-Targeted Therapy for Glioblastoma
The "Placebo Problem": How High Response Rates are Stalling Cancer Treatment Breakthroughs the-placebo-problem-how-high-response-rates-are-stalling-cancer-treatment-breakthroughs
  • Clinical Oncology Education

The "Placebo Problem": How High Response Rates are Stalling Cancer Treatment Breakthroughs

Neng Nana May 9, 2026 0
For decades, the oncology community has grappled with a persistent and frustrating reality: while researchers have made...
Read More Read more about The "Placebo Problem": How High Response Rates are Stalling Cancer Treatment Breakthroughs

Posts pagination

1 2 3 4 … 11 Next

Recent Posts

  • Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence
  • The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs
  • Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer
  • Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation
  • Beyond the Greige: Why Your Gym Wardrobe Needs a Color Revolution

Recent Comments

No comments to show.

Archives

  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

odyssey-therapeutics-secures-279-million-in-landmark-ipo-signaling-biotech-sector-resurgence
  • Chemotherapy and Targeted Therapy

Odyssey Therapeutics Secures $279 Million in Landmark IPO, Signaling Biotech Sector Resurgence

Raul Delapena Setiawan May 9, 2026 0
the-generous-model-evaluating-the-trump-administrations-strategy-to-curb-medicaid-drug-costs
  • Breast Cancer Legislation and Policy

The GENEROUS Model: Evaluating the Trump Administration’s Strategy to Curb Medicaid Drug Costs

Neng Nana May 9, 2026 0
breakthroughs-in-the-fight-against-stage-iv-new-research-cohort-targets-the-frontiers-of-metastatic-breast-cancer
  • Patient Advocacy and Support

Breakthroughs in the Fight Against Stage IV: New Research Cohort Targets the Frontiers of Metastatic Breast Cancer

Basiran May 9, 2026 0
empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation
  • Metastatic Breast Cancer Research

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation

Layla Zulfa May 9, 2026 0
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.